Immunogenicity of recombinant hepatitis B vaccine: Comparison of two different vaccination schedules

Infection

Volumn 38, Issue 4, 2010, Pages 269-273

  Agladioglu, S ^a   Beyazova, U ^a   Camurdan, A D ^a   Sahin, F ^a   Atak, A ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Hepatitis B vaccine; Immunity duration; Immunogenicity; Schedules

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; GEOMETRY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; MALE; TREATMENT DURATION; VACCINATION;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; STATISTICS AS TOPIC; VACCINES, SYNTHETIC;

EID: 77956057376     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0031-2     Document Type: Article

References (27)

1. K Van Herck P Van Damme 2008 Benefits of early hepatitis B immunization programs for newborns and infants Pediatr Infect Dis J 27 861 869 10.1097/INF.0b013e318173966f 18776823
2. A Demirjian O Levy 2009 Safety and efficacy of neonatal vaccination Eur J Immunol 39 36 46 10.1002/eji.200838620 1:CAS:528:DC%2BD1MXhs1Sitb0%3D 19089811
3. CY Lu BL Chiang WK Chi MH Chang YH Ni HM Hsu SJ Twu IJ Su LM Huang CY Lee 2004 Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination Hepatology 40 1415 1420 10.1002/hep.20490 15565627
4. SR Bialek WA Bower R Novak L Helgenberger SB Auerbach IT Williams BP Bell 2008 Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study Pediatr Infect Dis J 27 881 885 10.1097/INF. 0b013e31817702ba 18756185
5. LL Hammitt TW Hennessy AE Fiore C Zanis KB Hummel E Dunaway L Bulkow BJ McMahon 2007 Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years Vaccine 25 6958 6964 10.1016/j.vaccine.2007.06.059 1:CAS:528:DC%2BD2sXhtVCnsLjI 17714836
6. BJ McMahon DL Bruden KM Petersen LR Bulkow AJ Parkinson O Nainan M Khristova C Zanis H Peters HS Margolis 2005 Antibody levels of protection after hepatitis B vaccination: results of a 15-year follow-up Ann Intern Med 142 333 341 15738452
7. R del Canho PM Grosheide M Voogd WM Huisman RA Heijtink SW Schalm 1993 Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes J Med Virol 41 30 34 10.1002/jmv.1890410107 1:STN:280:DyaK2c%2FksFGrsA%3D%3D 8228934
8. S Bassily A Kotkat G Gray KC Hyams FM Brown IZ Imam R Arthur 1995 Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates Am J Trop Med Hyg 53 419 422 1:STN:280:DyaK28%2FnsVWmsA%3D%3D 7485697
9. CE Stevens PT Toy PE Taylor T Lee HY Yip 1992 Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection Pediatrics 90 170 173 1:STN:280:DyaK383ptl2itQ%3D%3D 1534885
10. Turkish Ministry of Health. Circular about extended program of immunization no: 1998/6856. Ankara: Turkish Ministry of Health.
11. Turkish Ministry of Health. Circular about extended program of immunization no: 2009/7941. Ankara: Turkish Ministry of Health.
12. W Szmuness CE Stevens EA Zang EJ Harley A Kellner 1981 A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report Hepatology 1 377 385 10.1002/hep.1840010502 1:STN:280: DyaL38%2FnsVahsQ%3D%3D 7030902
13. SC Hadler MA de Monzon DR Lugo M Perez 1989 Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians Vaccine 7 106 110 10.1016/0264-410X(89)90046-7 1:STN:280:DyaL1MzhvFWnsQ%3D%3D 2526419
14. W Jilg M Schmidt F Deinhardt 1989 Vaccination against hepatitis B: comparison of three different vaccination schedules J Infect Dis 160 766 769 1:STN:280:DyaK3c%2FjvVKhtQ%3D%3D 2530289
15. N Scheiermann M Gesemann C Maurer M Just R Berger 1990 Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules Vaccine 8 44 46 10.1016/0264-410X(90) 90217-A
16. RR Das JL Mathew RK Ratho S Dutta 2009 Randomized clinical trial comparing hepatitis B vaccine administered by 0, 6, and 14 week versus 6, 10, and 14 week schedule in healthy infants J Trop Pediatr 55 328 331 10.1093/tropej/fmp013 19264836
17. SW Schalm JA Mazel GC de Gast RA Heijtink MJ Botman JR Bänffer LJ Cerards J Zwijnenberg WP Fetter SM Nuijten YW Wladimiroff CML Chritensens 1989 Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen Pediatrics 83 1041 1048 1:STN:280:DyaL1M3mtlCksA%3D%3D 2726331
18. RD Weeratna CL Brazolot Millan MJ McCluskie CA Siegrist HL Davis 2001 Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies FEMS Immunol Med Microbiol 30 241 247 10.1111/j.1574-695X.2001.tb01577.x 1:CAS:528: DC%2BD3MXjtFGjtr0%3D 11335145
19. Y Hu Q Wu B Xu Z Zhou Z Wang YH Zhou 2008 Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants Vaccine 26 6064 6067 10.1016/j.vaccine.2008.09.014 1:CAS:528:DC%2BD1cXhtlGhu7nP 18812198
20. KM Petersen LR Bulkow BJ McMahon C Zanis M Getty H Peters AJ Parkinson 2004 Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth Pediatr Infect Dis J 23 650 655 10.1097/01.inf. 0000130952.96259.fd 15247604
21. D Seto DJ West VA Ioli 2002 Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth Pediatr Infect Dis J 21 793 795 10.1097/00006454-200208000-00021 12233715
22. DJ West B Watson J Lichtman TM Hesley K Hedberg 1994 Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy Pediatr Infect Dis J 13 745 747 10.1097/00006454-199408000-00015 1:STN:280:DyaK2M%2FmtFSqtg%3D%3D 7970979
23. KM Girisha JR Kamat G Nataraj 2006 Immunological response to two hepatitis B vaccines administered in two different schedules Indian J Pediatr 73 489 491 10.1007/BF02759892 1:STN:280:DC%2BD28zpsFahsg%3D%3D 16816509
24. Mathew JL, El Dib R, Mathew PJ, Boxall EH, Brok J. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status. Cochrane Database Syst Rev. 2008;16:CD006481.
25. European Consensus Group on Hepatitis B 2000 Immunity are booster immunisations needed for lifelong hepatitis B immunity? Lancet 355 561 565 10.1016/S0140-6736(99)07239-6
26. EE Mast CM Weinbaum AE Fiore MJ Alter BP Bell L Finelli LE Rodewald JM Douglas Jr RS Janssen JW Ward 2005 Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents MMWR Recomm Rep 54 RR-16 1 31 16371945
27. EUROHEP.NET. Recommendations for hepatitis B prevention strategies. Available at: www.eurohep.net. Accessed 22 March 2010.